Mesoblast (MESO) Return on Sales Growth (1y) (2015 - 2023)

Mesoblast (MESO) Return on Sales Growth (1y) (2015 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mesoblast 2.08 Bn 1.95 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -2.00
Mar 31, 2023 1.00
Dec 31, 2022 -4.00
Sep 30, 2022 2.00
Jun 30, 2022 -3.00
Mar 31, 2022 4.00
Dec 31, 2021 5.00
Sep 30, 2021 9.00
Jun 30, 2021 -5.00
Mar 31, 2021 -8.00
Dec 31, 2020 -1.00
Sep 30, 2020 -16.00
Jun 30, 2020 8.00
Mar 31, 2020 15.00
Dec 31, 2019 7.00
Sep 30, 2019 15.00
Jun 30, 2019 4.00
Mar 31, 2019 -4.00
Dec 31, 2018 -16.00
Sep 30, 2018 -6.00